Haisco Pharmaceutical Group Co.,Ltd.’s Net Profit Rose 2.5% in First Half of 2023

Haisco Pharmaceutical Group Co.,Ltd. (海思科医药集团股份有限公司) (002653.SZ) reported a net profit of 71.6 million yuan in the first half of 2023, up 2.5% year-on-year.

Meanwhile, the company posted 1.4 billion yuan in revenue, up 9.8% year-on-year.

At the end of the reporting period, it had 6.4 billion yuan in total assets and 2.3 billion yuan in total liabilities, with a liability-to-asset ratio of 36.5%.